These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5289041)

  • 21. Effect of prenatal insulin and glucagon injection on the glycogen content of rat placenta and fetal liver.
    Goltzsch W; Bittner R; Böhme HJ; Hofmann E
    Biomed Biochim Acta; 1987; 46(7):619-22. PubMed ID: 3322272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An assessment of the importance of intralysosomal and of alpha-amylolytic glycogenolysis in the liver of normal rats and of rats with a glycogen-storage disease.
    Vandebroeck A; Bollen M; De Wulf H; Stalmans W
    Eur J Biochem; 1985 Dec; 153(3):621-8. PubMed ID: 3878283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of hyperglucagonemia on hepatic glycogenolysis and gluconeogenesis after a prolonged fast.
    Hendrick GK; Frizzell RT; Williams PE; Cherrington AD
    Am J Physiol; 1990 May; 258(5 Pt 1):E841-9. PubMed ID: 2185665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR.
    Rothman DL; Magnusson I; Katz LD; Shulman RG; Shulman GI
    Science; 1991 Oct; 254(5031):573-6. PubMed ID: 1948033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucagon control of glycogenolysis in catfish tissues.
    Ottolenghi C; Puviani AC; Baruffaldi A; Gavioli ME; Brighenti L
    Comp Biochem Physiol B; 1988; 90(2):285-90. PubMed ID: 3409659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of glucagon and fructose in the control of glycogenolysis in perfused rat liver.
    Jakob A
    Mol Cell Endocrinol; 1976 Nov; 6(1):47-58. PubMed ID: 1001807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imbalance of liver phosphorylase and accumulation of hepatic glycogen in a girl with progressive disease of the brain.
    Hug G; Schubert WK; Shwachman H
    J Pediatr; 1965 Nov; 67(5):741-51. PubMed ID: 5215121
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and enzymological studies in a child with type I glycogen storage disease associated with partial deficiency of hepatic glucose-6-phosphatase.
    Nuki G; Parker J
    Adv Exp Med Biol; 1980; 122A():189-201. PubMed ID: 6158847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A glycogen storage disease (gsd/gsd) rat: studies on lipid metabolism, lipogenesis, plasma metabolites, and bile acid secretion.
    Clark DG; Topping DL; Illman RJ; Trimble RP; Malthus RS
    Metabolism; 1980 May; 29(5):415-20. PubMed ID: 6929400
    [No Abstract]   [Full Text] [Related]  

  • 30. Some cases of Type III glycogen storage disease.
    Rosenfield EL; Popova IA; Chibisov IV
    Clin Chim Acta; 1976 Mar; 67(2):123-30. PubMed ID: 1061645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct observation of glycogenesis and glucagon-stimulated glycogenolysis in the rat liver in vivo by high-field carbon-13 surface coil NMR.
    Reo NV; Siegfried BA; Ackerman JJ
    J Biol Chem; 1984 Nov; 259(22):13664-7. PubMed ID: 6501276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrinological findings in patients with glycogenosis.
    Bierich JR; Rager K; Schönberg D
    Acta Endocrinol Suppl (Copenh); 1973; 173():128. PubMed ID: 4542066
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects in vivo of food deprivation and 3-mercaptopicolinate in the glycogen-storage-disease (gsd/gsd) rat.
    Clark DG; Brinkman M; Neville SD; Haynes WD
    Biochem J; 1985 Nov; 231(3):755-9. PubMed ID: 3865652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demonstration of glycogen in glycogenosis types 1, 2 and 4.
    Byron FM
    J Med Lab Technol; 1970 Jan; 27(1):43-8. PubMed ID: 4904713
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of liver transplantation on hepatic glucose metabolism in a patient with type I glycogen storage disease.
    Koestinger A; Gillet M; Chioléro R; Mosimann F; Tappy L
    Transplantation; 2000 May; 69(10):2205-7. PubMed ID: 10852627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of gluconeogenesis after a 3-day fast does not deplete liver glycogen in patients with NIDDM.
    Clore JN; Blackard WG
    Diabetes; 1994 Feb; 43(2):256-62. PubMed ID: 8288050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of glucagon on hepatic glycogen and smooth endoplasmic reticulum.
    Striffler J; Cardell EL; Cardell RR
    Am J Anat; 1981 Apr; 160(4):363-79. PubMed ID: 7282565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diphenylhydantoin treatment of glycogen storage diseases.
    Jubiz W; Rallison ML
    Arch Intern Med; 1974 Sep; 134(3):418-21. PubMed ID: 4368592
    [No Abstract]   [Full Text] [Related]  

  • 39. [Glycogen metabolism abnormalities].
    Kitagawa T
    Naika; 1969 Apr; 23(4):661-9. PubMed ID: 4308632
    [No Abstract]   [Full Text] [Related]  

  • 40. Altered mechanism of glucagon-mediated hepatic glycogenolysis during long-term starvation in the rat.
    Goldstein DE; Sutherland CA; Curnow RT
    Metabolism; 1978 Oct; 27(10):1491-8. PubMed ID: 211368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.